Skip to main content
Clinical Medicine logoLink to Clinical Medicine
letter
. 2019 Jul;19(4):357–358. doi: 10.7861/clinmedicine.19-4-357a

Pulmonary embolism

Andrew Thompson 1
PMCID: PMC6752248  PMID: 31308127

Editor – The article on acute pulmonary embolism by L Howard covered most of the key areas of difficulty in managing patients presenting with a possible pulmonary embolism (PE),1 however the questions in the self-assessment continuing medical education (CME) were not very clear and in some cases contradict national guidelines.

Doppler ultrasound of the leg veins was recommended in investigating PEs in the pregnant patient, and in the CME was recommended in the absence of calf pain. The Royal College of Obstetricians and Gynaecologists guidelines were updated in 2015 to only recommend this investigation in patients with symptoms and signs of deep vein thrombosis (DVT).2 This is because of the high likelihood of false negative results as the patients have a higher incidence of isolated iliac vein DVT, or no DVT at all – in one case series, Chan et al found no cases of DVT in 67 women presenting with suspected PE.3

Another CME question highlights the difficulties with both the Wells score and cancer investigations. In Q10, one answer states a negative d-dimer would not avoid the need for a computed tomography pulmonary angiogram or ventilation–perfusion scan. This double negative means the Wells score has to be ‘unlikely’ for a suspected pulmonary embolism for this answer to be incorrect. The patient has a tachycardia of 108 beats per minute (1.5 on the Wells score) and there are three points available for whether a PE is considered the likely diagnosis or equally likely – which would take the score over four and therefore make a suspected PE ‘likely’.

This is the most difficult part of the Wells score and the terminology of this phrase varies. Wells originally described it as ‘the presence of an alternative diagnosis that was as likely, or more likely than pulmonary embolism to account for the patients signs and symptoms’ and went on to say it was possible to enrol a patient (into the study) with an alternative diagnosis of pneumonia if the physician still thought a PE could not be ruled out.4 In Q10 it is debateable whether a patient with chronic obstructive pulmonary disease (COPD) who describes 2 days of worsening dyspnoea and right sided chest pain, coughing up more clear sputum with some blood in the sputum can clearly be described as having an exacerbation of COPD without considering a PE – it would be helpful to know if they usually have a cough, their baseline saturations etc and patients with COPD are recognised to have as high a risk for venous thrombo-embolic (VTE) disease as the oral contraceptive pill and cancer (odds ratio between 2 and 9).5 Therefore, if the clinician thought that PE could not be ruled out then a negative d-dimer would not avoid the need for further investigations.

The same question has the correct answer as ‘if he is found to have a PE, he should have a computed tomography (CT) of the abdomen and pelvis’. While this may seem pedantic, the 2012 National Institute for Health and Care Excellence (NICE) guidelines (updated in 2015) only recommend that cancer screening be ‘considered’.6 The article was clearer on this distinction, but this remains an area under discussion. In 2012, the guideline group based this recommendation predominantly on the significant difference in VTE management of patients with cancer compared to those without cancer, both in terms of choice of anticoagulants and duration of anticoagulation, and the impact of this on VTE recurrence rates. They also concluded that patients might want to undergo further investigation knowing that the risk of cancer is 1 in 10 patients.

Subsequent studies suggest that the occult cancer rate may not be this high, (nearer 5% over a 30 month follow-up in one large prospective study).7 The 2018 Cochrane review found insufficient evidence to support this strategy.8 A UK cohort study reported that none of the CT abdomen/pelvis done as per the 2012 NICE recommendations for occult cancer screening in patient with unprovoked VTE revealed any occult cancer over a median follow-up period of 22 months.9

Clinicians should keep a low threshold for suspicion for cancer in patients presenting with unprovoked VTEs, and all patients should undergo a thorough medical history, examination, baseline laboratory blood tests and a chest X-ray if they did not undergo any chest imaging. There are further tools being developed to identify subsets of patients who would benefit from extensive screening, although they are not yet validated.10 An example of this is the RIETE prediction score in which, one point is assigned for male sex, chronic lung disease, or raised platelet count; two points are assigned for age >70 years or anaemia; and points are deducted for a postoperative or a prior VTE.11

References

  • 1.Howard L. Acute pulmonary embolism. Clin Med 2019;19:243–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Royal College of Obstetricians and Gynaecologists Thromboembolic disease in pregnancy and the puerperium: acute management. London: RCOG, 2015. [Google Scholar]
  • 3.Chan W, Ray J, Murray S, et al. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002;162:1170–5. [DOI] [PubMed] [Google Scholar]
  • 4.Wells P, Ginsberg J, Anderson D, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Annals of Int Med 1998;129:997–1005. [DOI] [PubMed] [Google Scholar]
  • 5.Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033–73. [DOI] [PubMed] [Google Scholar]
  • 6.National Institute for Health and Care Excellence Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. Clinical guideline [CG144]. NICE, 2015. [PubMed] [Google Scholar]
  • 7.van Doormaal F, Terpstra W, van der Griend R, et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 2011;9:79–84. [DOI] [PubMed] [Google Scholar]
  • 8.Robertson L, Yeoh S, Broderick C, et al. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE Cochrane Database Syst Rev 2018;11:CD010837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vaidyanathan S, Walsh J, Cliffe H, et al. Utility of additional abdominopelvic CT in detecting occult cancer in patients with unprovoked venous thromboembolism. Clin Radiol 2016;71:501–6. [DOI] [PubMed] [Google Scholar]
  • 10.Khan F, Rahman A, Carrier M. Occult cancer detection in venous thromboembolism: the past, the present, and the future. Res Pract Thromb Haemost 2017;1:9–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jara-Palomares L, Otero R, Jimenez D, et al. Development of a risk prediction score for occult cancer in patients with VTE. Chest 2017;151:564–71. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES